Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610428 · ClinicalTrials.gov registry record · Phase 2
Staccato Prochlorperazine in Migraine (in Clinic)
A Phase 2 study, sponsored by Alexza Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT00610428: Completed Phase 2 study, sponsored by Alexza Pharmaceuticals.
NCT00610428 is a Phase 2 study that has completed, run by Alexza Pharmaceuticals. The registered enrollment target is 75 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00610428, a Phase 2 study, has completed, sponsored by Alexza Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
Development of Staccato Prochlorperazine for the treatment of migraine headache.
Primary Outcome
patient headache pain relief defined as a 2 point reduction as measured on the scale: 0=NO headache pain, 1 = MILD headache pain, 2 = MODERATE headache pain, 3 = SEVERE headache pain
Interventions
- DRUG Staccato Placebo
- DRUG Staccato Prochlorperazine 5 mg
- DRUG Staccato Prochlorperazine 10 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
What the finished NCT00610428 record still lists
NCT00610428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 3 interventions - of which Staccato Placebo is the first listed.
NCT00610428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00610428 about?
NCT00610428 is a clinical study titled "Staccato Prochlorperazine in Migraine (in Clinic)". Development of Staccato Prochlorperazine for the treatment of migraine headache.
What is the current status of trial NCT00610428?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2005-03. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00610428?
The interventions under investigation include: Staccato Placebo (DRUG), Staccato Prochlorperazine 5 mg (DRUG), Staccato Prochlorperazine 10 mg (DRUG).
Who is sponsoring clinical trial NCT00610428?
This trial is sponsored by Alexza Pharmaceuticals, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00610428's enrollment target sits among peer trials
75 900th of 2000 higher than 1,081 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia